“…Non-surgical treatment modalities such as chemotherapy, immunotherapy and radiotherapy have significantly failed to improve overall survival, and surgery is the mainstay of treatment and offers the best hope for survival. [1][2][3][4] Recently, kinase inhibitors, including sorafenib, sunitinib and temsirolimus, were used in patients with metastatic renal cell carcinoma. 1,3,6,7 In conclusion, although metastatic renal cell carcinoma to the sphenoid sinus is rare, it might be considered in the differential diagnosis of masses in the paranasal sinus even long after initial treatment of renal cancer.…”